Si Bone Stock Performance
| SIBN Stock | USD 14.79 0.43 2.83% |
On a scale of 0 to 100, Si Bone holds a performance score of 5. The entity owns a Beta (Systematic Risk) of 1.71, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Si Bone will likely underperform. Please check Si Bone's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Si Bone's current price history will revert.
Risk-Adjusted Performance
Modest
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Si Bone are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental drivers, Si Bone displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 33.3 M |
SIBN |
Si Bone Relative Risk vs. Return Landscape
If you would invest 1,305 in Si Bone on December 19, 2024 and sell it today you would earn a total of 174.00 from holding Si Bone or generate 13.33% return on investment over 90 days. Si Bone is currently generating 0.2758% in daily expected returns and assumes 3.6876% risk (volatility on return distribution) over the 90 days horizon. In different words, 32% of stocks are less volatile than SIBN, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Si Bone Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Si Bone's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Si Bone, and traders can use it to determine the average amount a Si Bone's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0748
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SIBN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.69 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Si Bone is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Si Bone by adding it to a well-diversified portfolio.
Si Bone Fundamentals Growth
SIBN Stock prices reflect investors' perceptions of the future prospects and financial health of Si Bone, and Si Bone fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SIBN Stock performance.
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0956 | ||||
| Profit Margin | (0.18) % | ||||
| Operating Margin | (0.11) % | ||||
| Current Valuation | 513.41 M | ||||
| Shares Outstanding | 42.45 M | ||||
| Price To Book | 3.75 X | ||||
| Price To Sales | 3.87 X | ||||
| Revenue | 167.18 M | ||||
| EBITDA | (23.09 M) | ||||
| Cash And Equivalents | 114.41 M | ||||
| Cash Per Share | 3.34 X | ||||
| Total Debt | 2.03 M | ||||
| Debt To Equity | 0.36 % | ||||
| Book Value Per Share | 3.97 X | ||||
| Cash Flow From Operations | (12.43 M) | ||||
| Earnings Per Share | (0.75) X | ||||
| Total Asset | 230.44 M | ||||
| Retained Earnings | (431.35 M) | ||||
| Current Asset | 266 K | ||||
| Current Liabilities | 1.22 M | ||||
About Si Bone Performance
By examining Si Bone's fundamental ratios, stakeholders can obtain critical insights into Si Bone's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Si Bone is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Si Bone operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people.Things to note about Si Bone performance evaluation
Checking the ongoing alerts about Si Bone for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Si Bone help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Si Bone had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 167.18 M. Net Loss for the year was (30.91 M) with profit before overhead, payroll, taxes, and interest of 132.12 M. | |
| Si Bone currently holds about 114.41 M in cash with (12.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34. | |
| Si Bone has a poor financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are owned by institutional investors |
- Analyzing Si Bone's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Si Bone's stock is overvalued or undervalued compared to its peers.
- Examining Si Bone's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Si Bone's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Si Bone's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Si Bone's stock. These opinions can provide insight into Si Bone's potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.